Find your next paid study

Leiden University Medical CenterNCT06932081

Actual pay is set by the research site.

Transthyretin AmyloidosisHeart FailureHeart Failure, Diastolic+1 more

Prevalence and Prediction of Transthyretin Amyloidosis in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction

Recent studies have shown that transthyretin amyloidosis (ATTR) can sometimes cause a type of heart failure where the pumping function of the heart is normal, …

Massachusetts General HospitalNCT05577819

Actual pay is set by the research site.

GlioblastomaNewly Diagnosed GlioblastomaBrain Tumor

REMIND: An Investigator Initiated Study Testing the Feasibility of Maintenance Radiotherapy for Patients With Newly Diagnosed Glioblastoma

REMIND is a single-center feasibility study testing maintenance radiotherapy in adult patients with newly diagnosed glioblastoma. Participants will be consent…

University of MinnesotaNCT07831772

Actual pay is set by the research site.

Imaging Techniques in MRI

Background: \- Magnetic resonance imaging (MRI) scans must be performed according to specified sets of parameters that provide optimal images of each organ an…

Cardiac Risk FactorsHealthyHealthy Volunteers

National Institutes of Health Clinical Center (CC)NCT01130545

~$10 – $675

Actual pay is set by the research site.

Phase 1

Contrast Enhanced Digital Mammography for Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy

The purpose of this study is to compare a special type of mammogram that uses a contrast agent called contrast-enhanced digital mammography with contrast-enhan…

Breast CancerLocally Advanced Breast CancerNeoadjuvant Chemotherapy+3 more

Alison StopeckNCT06220214

~$150 – $4,500

Actual pay is set by the research site.

Phase 1

Phase 1 Study to Investigate the Dosimetry and Biodistribution of a Single Intravenous Administration of 99mTc-p5+14 Using SPECT/CT Imaging and Planar Gamma Scintigraphy in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis

This study will investigate 99mTc-p5+14, an amyloid-reactive synthetic peptide, p5+14, radiolabeled with technetium-99m, as a radiotracer for detecting paamylo…

Systemic Amyloidosis

University of Tennessee Graduate School of MedicineNCT05951816

~$500 – $7,500

Actual pay is set by the research site.

Phase 2

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

This is a randomized, phase II trial comparing staged stereotactic radiosurgery (SSRS) versus fractionated stereotactic radiotherapy (FSRT) in patients with la…

Brain MetastasesCancer (With CNS Involvement)

Medical University of South CarolinaNCT07227610

~$75 – $2,000

Actual pay is set by the research site.

Autism Spectrum DisorderSocial Anxiety Disorder

Application of Virtual Reality Technology to Treatment of Social Anxiety

The purpose of this study is to compare CBT VR exposure + VR social skills treatment to CBT Imaginal exposure + mindfulness, in reducing the severity of social…

The University of Texas Health Science Center, HoustonNCT06845488

Actual pay is set by the research site.

Phase 1

Phase I/II Trial of Gabapentin Plus Ketamine for Prevention and Treatment of Acute and Chronic Pain in Locally Advanced Head and Neck Cancer Patients Undergoing Primary or Adjuvant Chemoradiation

This is a study to establish a safe and feasible dose for prophylactic use of a combination of gabapentin and ketamine in head and neck cancer patients undergo…

Head and Neck CancerLocally Advanced Head and Neck Carcinoma

Natalie LockneyNCT05156060

~$150 – $4,500

Actual pay is set by the research site.

Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

To learn about the possible effects of a prebiotic food-enriched diet (PreFED) targeting the gut microbiome in participants with melanoma who are starting immu…

Unresectable Melanoma

M.D. Anderson Cancer CenterNCT06466434

Actual pay is set by the research site.

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of VERVE-102, a One-Time Dose Gene Editing Medicine, in Adults With or at High Risk for Atherosclerotic Cardiovascular Disease (ASCVD) Who Require Additional Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering

The purpose of this study is to measure the change in bad cholesterol (LDL-C) with VERVE-102 compared to placebo in adults who have plaque buildup in their art…

AtherosclerosisCardiovascular DiseaseHypercholesterolemia

Verve Therapeutics, Inc.NCT07839936

~$75 – $2,800

Actual pay is set by the research site.

Effectiveness and Implementation of a Brief Motivational Intervention to Increase Physical Activity for World Trade Center Health Program Cancer Survivors

The goal of this study is to test a brief motivational intervention to increase physical activity in a group of cancer survivors who are participants in the Wo…

Cancer